ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
152 hedge funds and large institutions have $489M invested in iTeos Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 45 increasing their positions, 57 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
+6
Holders Change %
+4.11%
% of All Funds
2.43%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
24
Increased
45
Reduced
57
Closed
17
Calls
$322K
Puts
$948K
Net Calls
-$626K
Net Calls Change
-$1.18M
Top Buyers
| 1 |
6CM
683 Capital Management
New York
|
+$4.49M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.41M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
+$2.06M |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$1.89M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.23M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$4.71M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$4.29M |
| 3 |
Morgan Stanley
New York
|
-$3.86M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.94M |
| 5 |
AP
Advisors Preferred
Rockville,
Maryland
|
-$1.69M |
